Loading clinical trials...
Loading clinical trials...
Effects of Acute Stress Exposure on Plasma Beta-amyloid Levels
Research has shown that activation of the sympathetic nervous system for extended periods or during certain times in life can increase the risk for Alzheimer's disease. Some research in animal models show that acute activation of the sympathetic nervous system through stress exposure can increase certain Alzheimer's disease-related biomarkers, such as amyloid-beta, within hours of exposure. However, how acute sympathetic nervous system activation via stress exposure affects amyloid-beta levels in humans has yet to be examined. In this study, the investigators will examine whether brief increases in sympathetic activation result in immediate changes in plasma amyloid-beta levels in the five hours after exposure.
Aim 1: determine whether acute exposure to stress (increasing sympathetic nervous system activation) increases plasma amyloid-beta-40 and amyloid-beta-42 in the five hours following exposure.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
Yes
University of Southern California
Los Angeles, California, United States
Start Date
December 5, 2023
Primary Completion Date
December 10, 2024
Completion Date
December 10, 2024
Last Updated
December 10, 2025
38
ACTUAL participants
Sympathetic Nervous System Activation
BEHAVIORAL
No-stress
BEHAVIORAL
Lead Sponsor
University of Southern California
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05723081